<VariationArchive VariationID="17303" VariationName="COL1A1, EX22DEL" VariationType="Deletion" Accession="VCV000017303" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-10" DateCreated="2013-04-04" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="32342" VariationID="17303">
      <GeneList>
        <Gene Symbol="COL1A1" FullName="collagen type I alpha 1 chain" GeneID="1277" HGNC_ID="HGNC:2197" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>17q21.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="50184101" stop="50201631" display_start="50184101" display_stop="50201631" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="48261456" stop="48278999" display_start="48261456" display_stop="48278999" Strand="-" />
          </Location>
          <OMIM>120150</OMIM>
          <Haploinsufficiency last_evaluated="2012-08-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=COL1A1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-08-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=COL1A1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>COL1A1, EX22DEL</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q21.31-q22</CytogeneticLocation>
      </Location>
      <OtherNameList>
        <Name>EX22DEL</Name>
      </OtherNameList>
      <XRefList>
        <XRef Type="Allelic variant" ID="120150.0020" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="COL1A1, EX22DEL AND Osteogenesis imperfecta type III" Accession="RCV000018844" Version="23">
        <ClassifiedConditionList TraitSetID="5676">
          <ClassifiedCondition DB="MedGen" ID="C0268362">Osteogenesis imperfecta type III</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2023-01-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-01-17" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2013-04-04" MostRecentSubmission="2024-06-09">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <CitationText>Wallis, G. A., Starman, B. J., Byers, P. H. Clinical heterogeneity of OI explained by molecular heterogeneity and somatic mosaicism. (Abstract) Am. J. Hum. Genet. 45: A228, 1989.</CitationText>
        </Citation>
        <ConditionList>
          <TraitSet ID="5676" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3679" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Osteogenesis imperfecta type III</ElementValue>
                <XRef ID="Osteogenesis+imperfecta+type+3/5458" DB="Genetic Alliance" />
                <XRef ID="385483009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta type 3</ElementValue>
                <XRef ID="MONDO:0009804" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">OI type 3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta, progressively deforming with normal sclerae</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OI type III</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">COL1A1</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">OI3</ElementValue>
                <XRef Type="MIM" ID="259420" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8695" />
                <XRef ID="8695" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">COL1A1/2 osteogenesis imperfecta (COL1A1/2-OI) is characterized by fractures with minimal or absent trauma, variable dentinogenesis imperfecta (DI), and, in adult years, hearing loss. The clinical features of COL1A1/2-OI represent a continuum ranging from perinatal lethality to individuals with severe skeletal deformities, mobility impairments, and very short stature to nearly asymptomatic individuals with a mild predisposition to fractures, normal dentition, normal stature, and normal life span. Fractures can occur in any bone but are most common in the extremities. DI is characterized by gray or brown teeth that may appear translucent, wear down, and break easily. COL1A1/2-OI has been classified into four types based on clinical presentation and radiographic findings. This classification system can be helpful in providing information about prognosis and management for a given individual. The four more common OI types are now referred to as follows: Classic non-deforming OI with blue sclerae (previously OI type I). Perinatally lethal OI (previously OI type II). Progressively deforming OI (previously OI type III). Common variable OI with normal sclerae (previously OI type IV).</Attribute>
                <XRef ID="NBK1295" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301472</ID>
                <ID Source="BookShelf">NBK1295</ID>
              </Citation>
              <Citation Type="general" Abbrev="EMQN, 2012">
                <ID Source="pmc">3234509</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2008">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_OsteogenesisImperfecta.pdf</URL>
                <CitationText>Orphanet Emergency Guidelines: Osteogenesis imperfecta (OI)</CitationText>
              </Citation>
              <XRef ID="216812" DB="Orphanet" />
              <XRef ID="666" DB="Orphanet" />
              <XRef ID="C0268362" DB="MedGen" />
              <XRef ID="MONDO:0009804" DB="MONDO" />
              <XRef Type="MIM" ID="259420" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="39127" SubmissionDate="2013-04-04" DateLastUpdated="2024-06-09" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="120150.0020_OSTEOGENESIS IMPERFECTA, TYPE III" title="COL1A1, EX22DEL_OSTEOGENESIS IMPERFECTA, TYPE III" />
        <ClinVarAccession Accession="SCV000039127" DateUpdated="2024-06-09" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-01-17">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Wallis et al. (1989) described a mutation in COL1A1 resulting in the deletion of exon 22 during RNA processing. The phenotype was progressive deforming OI (OI3; 259420).</Attribute>
              <Citation>
                <CitationText>Wallis, G. A., Starman, B. J., Byers, P. H. Clinical heterogeneity of OI explained by molecular heterogeneity and somatic mosaicism. (Abstract) Am. J. Hum. Genet. 45: A228, 1989.</CitationText>
              </Citation>
              <XRef DB="OMIM" ID="259420" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL1A1" />
          </GeneList>
          <Name>COL1A1, EX22DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">EX22DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="120150.0020" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">OSTEOGENESIS IMPERFECTA, TYPE III</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="39127" TraitType="Disease" MappingType="Name" MappingValue="OSTEOGENESIS IMPERFECTA, TYPE III" MappingRef="Preferred">
        <MedGen CUI="C0268362" Name="Osteogenesis imperfecta type III" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

